Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Biomedical Property Modifications of Poly(vinyl Chloride) with Methoxylated Poly(ethylene Glycol)‐poly(ε‐caprolactone) Diblock Copolymer

Poly(L-Lactide) Materials with Balanced Mechanical Properties Prepared by Blending with Peg-Mb-Ppa Multiblock Copolymers

Synthesis of PVC-b-PEG Copolymer and Its Modification Effect on PVC Microfiltration Membrane

Modulating Drug Release from Short Poly(ethylene Glycol) Block Initiated Poly(L-lactide) Di-block Copolymers

Synthesis Internal-Plasticized PVC Copolymer Resin from Industrial Application View: Copolymerization of Vinyl Chloride with Poly(ethylene Glycol) Monomethyl Ether Methacrylate Via Suspension Polymerization

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Chemical modification of poly(vinyl chloride) resin using poly(ethylene glycol) to improve blood compatibility

A New Generation of Poly(lactide/ε-Caprolactone) Polymeric Biomaterials for Application in the Medical Field.

Thermal, Mechanical and Degradation Properties of Flexible Poly (1,3-Trimethylene Carbonate)/poly (L-Lactide-co-ε-caprolactone) Blends

Synthesis And Solution Properties Of Ph Responsive Methoxy Poly(Ethylene Glycol)-B-Poly(Gamma-Amino-Epsilon-Caprolactone)

Comparative Studies on Hydrophilic and Hydrophobic Segments Grafted Poly(vinyl chloride)

Poly(1,2-Propylene Glycol Adipate) As an Environmentally Friendly Plasticizer for Poly(Vinyl Chloride)

Flexible Poly(vinyl chloride) with Durable Antibiofouling Property via Blending Star-Shaped Amphiphilic Poly(ε-caprolactone)- block -poly(methacryloxyethyl sulfobetaine)

Novel Designed PEG‐Dicationic Imidazolium‐Based Ionic Liquids as Effective Plasticizers for Sustainable Polylactide

Improving microinjection processability of biodegradable elastomer poly(l‐lactide‐co‐ε‐caprolactone) by blending with polycaprolactone and plasticizing with polyethylene glycol

Effects of Poly(ε-caprolactone) on the Properties of Poly (lactic acid)/Poly (butylene succinate) Blends

Biodegradable PVC plasticizer derived from a new CO2-based Poly(carbonate-ester) macrodiol: Molecular design and plasticizing effect

Biocompatibility studies and characterization of poly(3-hydroxybutyrate-<i>co</i>-3-hydroxyhexanoate)/polycaprolactone blends

Biocompatibility studies and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)/polycaprolactone blends.

Synthesis, characterization and biocompatibility of novel biodegradable poly[((R)-3-hydroxybutyrate)-block-(D,L-lactide)-block-(ɛ-caprolactone)] triblock copolymers

Influence of Biodegradable Poly(butylene Carbonate) on Plasticized Polylactide Blown Films